Jodi Rubin, MD
Allergy · Scottsdale, AZNPI 1255473872
Payments from drug & device makers
Across 575 payments — averaging $51.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$14K
- Regeneron Healthcare Solutions, Inc.$7K
- GSK$2K
- Optinose US, Inc.$1K
- AstraZeneca$1K
- CSL Behring$972
- plus $4K from 22 others
What the payments were for
- Speaking & faculty fees$17,24358%
- Travel & lodging$30%
- Food & beverage$12,14841%
- Education$1120%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 88 | $13,694 |
| Regeneron Healthcare Solutions, Inc. | 68 | $7,004 |
| GSK | 75 | $1,553 |
| Optinose US, Inc. | 82 | $1,495 |
| AstraZeneca | 58 | $1,092 |
| CSL Behring | 38 | $972 |
| Aerin Medical Inc. | 18 | $687 |
| Takeda Pharmaceuticals U.S.A., Inc. | 50 | $687 |
| Inspire Medical Systems, Inc. | 23 | $588 |
| Novartis | 17 | $383 |
| Genentech USA, Inc. | 13 | $380 |
| Amgen | 13 | $242 |
| Kaleo, Inc. | 5 | $112 |
| Sanofi-aventis U.S. LLC | 1 | $100 |
| Merck | 3 | $69 |
| Pharming Healthcare, Inc. | 3 | $62 |
| Hikma Pharmaceuticals USA | 3 | $59 |
| Shire North American Group Inc | 4 | $58 |
| Intersect ENT, Inc. | 2 | $38 |
| Medtronic | 1 | $38 |
| Smith+Nephew | 2 | $38 |
| LEO Pharma Inc. | 2 | $37 |
| Jubilant Hollisterstier LLC | 1 | $36 |
| Arcutis Biotherapeutics, Inc. | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Stryker | 1 | $17 |
| Aimmune Therapeutics, Inc. | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DUPIXENT$17,934
- Xhance$259
- TEZSPIRE$236
- Inspire Upper Airway Stimulation System$215
- VIVAER STYLUS$149
- RHINAER STYLUS$149
- XOLAIR$148
- Vivaer RF Stylus$109
How this compares
Too few allergy providers in Arizonato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 38 | $152,554 |
| TezspireTezepelumab-Ekko | 11 | $43,363 |
| Breo ElliptaFluticasone/Vilanterol | 18 | $9,766 |
| Wixela InhubFluticasone Propion/Salmeterol | 13 | $1,667 |
| Azelastine Hcl | 44 | $1,593 |
| Fluticasone Propionate | 28 | $777 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 20 | $494 |
| Montelukast Sodium | 77 | $477 |
| Ipratropium Bromide | 12 | $339 |
| Prednisone | 18 | $21 |
| Famotidine | 11 | $14 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaTezspire | $1,092 | $43,36311 claims |
| GSKBreo Ellipta | $1,553 | $9,76618 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few allergy providers in Arizonaon file to place this against a meaningful peer group, so we don't.
Other allergy in Scottsdale
- Julie WendtScottsdale$16K
- Hugh MackechnieScottsdale$413
- Linda Alvarez ThullScottsdale$24
- Todd HrabakGlendale$436K
- Allan WachterPhoenix$4K
- Richard KeightleyPhoenix$402
- Rahmat AfrasiabiPrescott$211
- Eddie GainesAnthem$44
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.